BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 12, 2015
View Archived Issues
World Glaucoma Week: Novel agent is beneficial in model of intraocular hypertension
Read More
Northeastern University patents CB1 receptor modulators
Read More
CureVac patent describes antiviral combination vaccines
Read More
LG Life Sciences discloses necrosis and apoptosis inhibitors
Read More
Bioavailability studies support marketing applications for Bekinda
Read More
Taiho Pharmaceutical reports development of BTK inhibitors
Read More
FGFR and steroid hormone receptors could serve as thyroid cancer biomarkers
Read More
BMS-938790, a PEG-adnectin targeting hIL-23, for treatment of inflammatory diseases
Read More
SNP in TRMT11 gene described as potential biomarker in advanced-stage CRPC
Read More
Interleukin Genetics to provide genomic testing service for Isis phase I trial
Read More
University of Toronto divulges new anti-Frizzled antibodies
Read More
Bayer submits MAA for aflibercept for myopic choroidal neovascularization
Read More
Rotavac vaccine launched in India
Read More
Hua Medicine files IND in U.S. for HMS-5552
Read More
Alcobra's MDX meets primary endpoint in phase II trial in ADHD
Read More
Phase II trial of TKM-Ebola-Guinea starts in Sierra Leone
Read More
Dimethandrolone shows potential for male contraception
Read More
InMed Pharmaceuticals and University of Debrecen to develop cannabinoids for ocular allergy
Read More
Celgene gains access to Open Monoclonal Technology's OmniAb platform
Read More
Therapure cleared to begin phase I trial of TBI-304H for chemotherapy-induced anemia
Read More
Collegium raises financing to advance Xtampza ER to launch
Read More
Antibe Therapeutics resumes development of ATB-346 following review of phase I data
Read More
Zogenix sells Zohydro ER extended-release hydrocodone to Pernix Therapeutics
Read More
University of Tokyo and Sanofi collaborate in inflammatory diseases and oncology
Read More